We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

XCH:NASDAQXCHG Limited Analysis

Data as of 2026-08-31 - not real-time

$3.55

Latest Price

9/10Risk

Risk Level: High

Executive Summary

XCHG Limited trades at $3.55, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Across the trailing 30 sessions it lost 70.2%. Momentum indicators put RSI at 21.6 (oversold) with MACD reading bullish. The recent range runs from support at $3.51 up to resistance at $11.40.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is contracting at 42.6% on a -129.5% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 118.1%, a beta of 1.82 and a maximum drawdown of 91.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to sell, carrying 5/10 conviction.

Top Market Events

HAMBURG, Germany and AUSTIN, Texas, Aug. 19, 2026 GLOBE NEWSWIRE -- XCHG Limited "XCharge" or the "Company" Nasdaq: XCH...tradingkey10dXCHG Ltd Stock XCH Moved Up by 2064.tradingkey5dXCHG Ltd Stock XCH Moved Down by 7.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 21.6 signals oversold conditions
  • Trading below the 200-day average of 18.26

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 21.6 signals oversold conditions
  • Trading below the 200-day average of 18.26

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Negative profit margin of -129.5%
  • Negative return on equity of -137.2%
  • Revenue contracting at -42.6%

Key Metrics & Analysis

Financial Health

Revenue Growth-42.60%
Profit Margin-129.49%
P/E Ratio-118.3
ROE-137.21%
ROA-40.85%
Debt/Equity45.73
P/B Ratio14.4
Op. Cash Flow$-7526683
Free Cash Flow$1.4M
Industry P/E29.0

Technical Analysis

TrendBearish
RSI21.6
Support$3.51
Resistance$11.40
MA 20$5.19
MA 50$9.94
MA 200$18.26
MACDBullish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$4.76
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.82
Volatility118.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.